C. McElree

发表

Distinct associations of HLA class II genes with inflammatory bowel disease.

S. Targan, J. Rotter, F. Shanahan, 1993, Gastroenterology.

A genome-wide search identifies potential new susceptibility loci for Crohn's disease.

S. Targan, Huiying Yang, J. Rotter, 1999, Inflammatory bowel diseases.

Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity.

S. Targan, R. Duerr, Huiying Yang, 1992, Gastroenterology.

Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers.

S. Targan, J. Rotter, H. Yang, 1993, The Journal of clinical investigation.

Familial empiric risk estimates of inflammatory bowel disease in Ashkenazi Jews.

J. Rotter, G. Petersen, J. Panish, 1989, Gastroenterology.

Intestinal permeability in patients with Crohn's disease and their healthy relatives.

J. Rotter, C. Vadheim, T. Delahunty, 1989, Gastroenterology.

Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews.

S. Targan, Huiying Yang, J. Rotter, 1993, Gut.

Geographic origins of Jewish patients with inflammatory bowel disease.

J. Rotter, G. Petersen, M. Roth, 1989, Gastroenterology.

Linkage of Crohn’s disease to the major histocompatibility complex region is detected by multiple non-parametric analyses

S. Targan, K. Taylor, Huiying Yang, 1999, Gut.

A genome-wide search identifies potential new susceptibility loci for Crohn's disease

S. Targan, Huiying Yang, J. Rotter, 1999 .

Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn's disease, but not in ulcerative colitis.

S. Targan, Huiying Yang, J. Rotter, 1996, Human molecular genetics.